We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Details Submission Requirements for New Regenerative Advanced Therapy Designation
FDA Details Submission Requirements for New Regenerative Advanced Therapy Designation
The FDA has introduced a new designation for regenerative medicine therapies, laying out the submission requirements for sponsors seeking the expedited review that stems from the 21st Century Cures Act.